Health and Me

Supriya Ramesh

Think It Is Just a Cold? It Could Be Allergic Rhinitis, and Here is Why Early Testing and Treatment Matter

Credits: Canva

When the sniffles will not stop and your mornings start with continuous sneezing, it is natural to assume you have caught a cold. But what if it is something more persistent, like <span>allergic rhinitis</span>?

<strong>What is allergic rhinitis?</strong>

Allergic rhinitis is an allergic reaction that occurs when your immune system overreacts to allergens like pollen, <span>dust mites</span>, animal dander, or mould. This common condition is marked by a suite of symptoms, including sneezing spells, a runny or blocked nose, itchy, watery eyes, post-nasal drip, fatigue, poor sleep, and constant coughing. Unlike the common cold, it is not caused by a virus, and symptoms can persist for weeks or months or even all year round. 

Dr. Manish Arya of the ENT, Allergy and Vertigo Clinic points out that “most people with allergies are unaware of the exact trigger causing their symptoms. That is where the <span>skin prick test</span> (SPT) comes in.”

This quick, safe diagnostic tool involves pricking tiny amounts of various allergens into the skin—typically on the forearm or back. “If you are allergic to a substance, a small red bump (like a mosquito bite) appears in 15–20 minutes,” he explains.

<strong>The benefits of the SPT are many:</strong>

<ul><li>It helps identify specific allergens such as dust mites, pollens, fungi, pets, or certain foods.</li><li>It guides both avoidance strategies and treatment plans.</li><li>It is painless – just small skin pricks!</li></ul>

<strong>What is allergy <span rel="noindex">immunotherapy</span>? </strong>

While most people turn to <span>antihistamines</span> or nasal sprays, Dr. Arya says that these only provide temporary relief. “That is where immunotherapy comes into play; it is like a vaccine for your allergy,” he says. Immunotherapy aims to gradually desensitise the immune system to allergens and is the only known method to reduce allergies in the long term. 

According to Dr Arya, it can be administered through:

<ul><li>Allergy shots (Subcutaneous Immunotherapy or SCIT)</li><li>Under-the-tongue drops/tablets (Sublingual Immunotherapy or SLIT)</li></ul>These are tailor-made based on your skin prick test results.

<strong>What does immunotherapy offer?</strong>

<ul><li>Reduces symptom severity over time.</li><li>Decreases dependency on medicines.</li><li>Prevents worsening of allergies or the development of asthma.</li><li>Safe for children and adults.</li></ul>

Dr. Arya emphasises, “It is a long-term investment in your health, usually taken over 3 years. In some cases, it may be extended up to 5 years. It does not contain any steroids or antihistamines and is completely natural.”

<strong>Why Early Testing and Treatment Matter</strong>

“Allergic rhinitis is not just a nuisance,” warns Dr. Arya. If left untreated, it can:

<ul><li>Over a period of time, it may worsen to asthma as well in about 50 per cent of cases.</li><li>Cause recurrent sinus infections.</li><li>Affect sleep and work/school performance.</li><li>Lead to ear problems in children.</li></ul>He stresses that early detection via skin prick testing and starting immunotherapy can stop the allergy in its tracks.

“Allergies can take a toll on your quality of life,” Dr. Arya says. So instead of just popping pills every season, it is time to find out what you are allergic to and treat the root cause. Skin prick testing and immunotherapy have transformed how we manage allergic rhinitis today.”

<strong>Quick Allergy Checklist – Do You Have It?</strong>

<ul><li>Frequent sneezing, especially in the mornings</li><li>Nasal congestion or watery discharge</li><li>Itchy eyes or throat</li><li>Symptoms triggered by dust, pollen, or pets – or sometimes without any trigger!</li><li>No fever (unlike colds)</li></ul>Dr Arya advises: “If you checked more than two, it is time to see an ENT or allergy specialist!”

Health Conditions A-Z

health

allergic rhinitis

skin prick test

immunotherapy

allergy symptoms

antihistamines

ent specialist

dust mites

pollen allergy

asthma prevention

allergy diagnosis

New Oral Treatment Offers Hope For MS Patients Battling Muscle Spasticity

Flesh-Eating Bacteria Claims 4 Lives in Florida: What You Should Know

'Pretty Little Baby' Singer Connie Francis Passes Away At 87, What Happened To Her?

Health & Wellness

Experiencing Headaches At Word? Natural Remedies To Try

Yoga Poses That Enhance Digestion

Health Benefits of Walking Backwards

No Eggs? Egg-Alternatives You Can Add To Your Diet

Savory And Smart Ways To Add Broccoli To Your Diet

Calorie Burning Habits That Can Help You Shed Extra Pounds

Yoga Poses That Can Help With Bloating

Fiber-Rich Oatmeal Dishes You Can Have For Breakfast

Signs You Must Visit A Doctor For Your Back Pain

Avocado Meal Prep Ideas To Increase Healthy Fat In Your Diet

Arm Exercises You Can Do At Home

Quick-Office Lunches That Can Keep You Full-Longer

How Increased Screen Time Affects Children's Health

Homemade Recipe To Make Protein-Rich Pancakes With Healthy Alternatives

Push-Up Variations You Can Do At Home

Common Mistakes Running Mistakes People Make

Low-Calorie Foods That Keep You Full For Long

Yoga Poses That Help You Get Rid Of Back Pain

Natural Ways To Increase Protein In Your Diet

Managing Excessive Daytime Sleepiness – Tips To Try

How Much Protein Is Too Much?

High Fiber Indian Foods You Should Try

10 Easy Ways To Boost Daily Fiber Intake

Adding Walnut Oil To Your Diet? Benefits You Should Know

Drinks That Soothe Headaches And Migraines

Waist Exercises For More Toned Belly

This Is How Stress Affects Your Heart

Does Digital ‘Brain Rot’ Really Affect Your Health?

Dishes With Fermented Foods To Eat For Your Gut Health

Yoga Poses That Stimulate Good Bowel Health

Weekend Warrior Exercises For Full Body Movement

Weekend Meal Prep Ideas That Will Last You A Weekend

Easy Homemade Healthy Dishes For Long Afternoons

Silent Walking: Mental Health Booster That Keeps You Fit

Dumbbell Exercises You Can Do At Home

These Foods Are Keeping You Awake At Night

Ways to Manage Sugar Cravings

Your Body Doesn’t Want You To Lose Weight – Here's It Resists

High-Protein No Cook Dishes You Should Try

Yoga Poses That Aid In Digestion

When the sniffles will not stop and your mornings start with continuous sneezing, it is natural to assume you have caught a cold. But what if it is something more persistent, like allergic rhinitis?What is allergic rhinitis?Allergic rhinitis is an allergic reaction that occurs when your immune system overreacts to allergens like pollen, dust mites, animal dander, or mould. This common condition is marked by a suite of symptoms, including sneezing spells, a runny or blocked nose, itchy, watery eyes, post-nasal drip, fatigue, poor sleep, and constant coughing. Unlike the common cold, it is not caused by a virus, and symptoms can persist for weeks or months or even all year round. How is it diagnosed? Dr. Manish Arya of the ENT, Allergy and Vertigo Clinic points out that “most people with allergies are unaware of the exact trigger causing their symptoms. That is where the skin prick test (SPT) comes in.”This quick, safe diagnostic tool involves pricking tiny amounts of various allergens into the skin—typically on the forearm or back. “If you are allergic to a substance, a small red bump (like a mosquito bite) appears in 15–20 minutes,” he explains.The benefits of the SPT are many:It helps identify specific allergens such as dust mites, pollens, fungi, pets, or certain foods.It guides both avoidance strategies and treatment plans.It is painless – just small skin pricks!What is allergy immunotherapy? While most people turn to antihistamines or nasal sprays, Dr. Arya says that these only provide temporary relief. “That is where immunotherapy comes into play; it is like a vaccine for your allergy,” he says. Immunotherapy aims to gradually desensitise the immune system to allergens and is the only known method to reduce allergies in the long term. According to Dr Arya, it can be administered through:Allergy shots (Subcutaneous Immunotherapy or SCIT)Under-the-tongue drops/tablets (Sublingual Immunotherapy or SLIT)These are tailor-made based on your skin prick test results.What does immunotherapy offer?Reduces symptom severity over time.Decreases dependency on medicines.Prevents worsening of allergies or the development of asthma.Safe for children and adults.Dr. Arya emphasises, “It is a long-term investment in your health, usually taken over 3 years. In some cases, it may be extended up to 5 years. It does not contain any steroids or antihistamines and is completely natural.”Why Early Testing and Treatment Matter“Allergic rhinitis is not just a nuisance,” warns Dr. Arya. If left untreated, it can:Over a period of time, it may worsen to asthma as well in about 50 per cent of cases.Cause recurrent sinus infections.Affect sleep and work/school performance.Lead to ear problems in children.He stresses that early detection via skin prick testing and starting immunotherapy can stop the allergy in its tracks.“Allergies can take a toll on your quality of life,” Dr. Arya says. So instead of just popping pills every season, it is time to find out what you are allergic to and treat the root cause. Skin prick testing and immunotherapy have transformed how we manage allergic rhinitis today.”Quick Allergy Checklist – Do You Have It?Frequent sneezing, especially in the morningsNasal congestion or watery dischargeItchy eyes or throatSymptoms triggered by dust, pollen, or pets – or sometimes without any trigger!No fever (unlike colds)Dr Arya advises: “If you checked more than two, it is time to see an ENT or allergy specialist!”

think it is just a cold? it could be allergic rhinitis, and here is why early testing and treatment matter

Ishita Roy

Health News

Forget Blood Tests Now Dogs Can Sniff Out Parkinson’s Before Symptoms Appear

forget blood tests now dogs can sniff out parkinson’s before symptoms appear

Understanding Soft Tissue Sarcoma: When Should You Be Concerned About A Lump?

understanding soft tissue sarcoma: when should you be concerned about a lump?

Most Common Cause Of High Blood Pressure May Be The Most Overlooked One - New Guidelines Reveal

most common cause of high blood pressure may be the most overlooked one - new guidelines reveal

This Age-Old Killer Is Spreading Fast, Why Super Typhoid Isn’t Just A ‘Poor Country’ Problem Anymore

this age-old killer is spreading fast, why super typhoid isn’t just a ‘poor country’ problem anymore

For many individuals living with <span>multiple sclerosis</span> (<span>MS</span>), muscle spasticity, an often painful and limiting symptom, can be one of the most persistent and frustrating aspects of the disease. Characterized by stiff or tight muscles that resist movement, spasticity can interfere with basic activities like walking, dressing, or even sleeping. But an encouraging breakthrough may be on the horizon.

Researchers at the University of Cincinnati’s Gardner Neuroscience Institute are currently conducting a promising Phase 2 clinical trial for a new oral drug that targets the body’s endocannabinoid system, a natural internal mechanism that helps regulate muscle tone and relaxation. Rather than introducing an external muscle relaxant, this treatment is designed to enhance the body’s own ability to ease muscle stiffness by preventing the breakdown of naturally occurring compounds called endocannabinoids.

“Our goal is to find a treatment that’s not only effective, but also better tolerated during the day,” said Dr. Shahla Hosseini, MD, PhD, in a statement released by the university. “Most existing oral medications come with side effects like drowsiness or fatigue, which can significantly reduce a patient’s quality of life.”

The new treatment under investigation inhibits specific enzymes that normally break down endocannabinoids in the body. These endocannabinoids function like the body’s natural muscle relaxers, but in people with MS, their levels tend to be low. By elevating endocannabinoid levels, the drug aims to restore better muscle control without the sedation that plagues current treatments.

This trial will involve approximately 200 participants from multiple international sites, making it a robust, multicenter effort. Over a period of six weeks, participants will be randomly assigned to receive one of three different doses of the study drug or a placebo. There’s also an optional six-week extension, which allows all participants to potentially receive the active drug and helps researchers compare the varying doses more effectively.

If successful, the trial could pave the way for a new class of medications to be used in tandem with current therapies like physiotherapy and botulinum toxin (Botox) injections. The drug’s oral format also means it could offer a non-invasive, easier-to-manage option for long-term symptom relief.

While this trial is focused on MS-related spasticity, researchers are hopeful that the drug could eventually help individuals with other neurological disorders that impact muscle control, including spinal cord injuries, cerebral palsy, and stroke. This makes the study’s success particularly significant, not just for those with MS, but for a wider community of patients affected by similar conditions.

<h4>What is Multiple Sclerosis (MS)?</h4>

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system—including the brain and spinal cord. In MS, the immune system mistakenly attacks the protective sheath (myelin) that covers nerve fibers, disrupting the communication between the brain and the rest of the body. Over time, this can lead to nerve damage and deterioration.

<ul><li>Muscle spasticity or stiffness</li><li>Fatigue</li><li>Difficulty walking or maintaining balance</li><li>Vision problems (e.g., blurred or double vision)</li><li>Numbness or tingling, especially in the limbs</li><li>Cognitive difficulties</li><li>Bladder and bowel dysfunction</li><li>Pain or muscle cramps</li></ul>

Symptoms can vary widely depending on the area of the nervous system affected, and they often come and go in episodes known as relapses.

Diagnosing MS can be complex and typically involves a combination of:

<ul><li>Neurological exams to assess reflexes, vision, coordination, and balance</li><li>MRI scans to detect lesions or areas of demyelination in the brain or spinal cord</li><li>Lumbar puncture (spinal tap) to examine cerebrospinal fluid for specific immune markers</li><li>Evoked potential tests to measure electrical activity in response to stimuli</li></ul>

There’s no single test for MS, so diagnosis often involves ruling out other conditions with similar symptoms.

Multiple Sclerosis (MS)

health and wellness

multiple sclerosis

MS treatment

For many individuals living with multiple sclerosis (MS), muscle spasticity, an often painful and limiting symptom, can be one of the most persistent and frustrating aspects of the disease. Characterized by stiff or tight muscles that resist movement, spasticity can interfere with basic activities like walking, dressing, or even sleeping. But an encouraging breakthrough may be on the horizon.Researchers at the University of Cincinnati’s Gardner Neuroscience Institute are currently conducting a promising Phase 2 clinical trial for a new oral drug that targets the body’s endocannabinoid system, a natural internal mechanism that helps regulate muscle tone and relaxation. Rather than introducing an external muscle relaxant, this treatment is designed to enhance the body’s own ability to ease muscle stiffness by preventing the breakdown of naturally occurring compounds called endocannabinoids.“Our goal is to find a treatment that’s not only effective, but also better tolerated during the day,” said Dr. Shahla Hosseini, MD, PhD, in a statement released by the university. “Most existing oral medications come with side effects like drowsiness or fatigue, which can significantly reduce a patient’s quality of life.”How the New Drug WorksThe new treatment under investigation inhibits specific enzymes that normally break down endocannabinoids in the body. These endocannabinoids function like the body’s natural muscle relaxers, but in people with MS, their levels tend to be low. By elevating endocannabinoid levels, the drug aims to restore better muscle control without the sedation that plagues current treatments.This trial will involve approximately 200 participants from multiple international sites, making it a robust, multicenter effort. Over a period of six weeks, participants will be randomly assigned to receive one of three different doses of the study drug or a placebo. There’s also an optional six-week extension, which allows all participants to potentially receive the active drug and helps researchers compare the varying doses more effectively.If successful, the trial could pave the way for a new class of medications to be used in tandem with current therapies like physiotherapy and botulinum toxin (Botox) injections. The drug’s oral format also means it could offer a non-invasive, easier-to-manage option for long-term symptom relief.Broader Potential Beyond MSWhile this trial is focused on MS-related spasticity, researchers are hopeful that the drug could eventually help individuals with other neurological disorders that impact muscle control, including spinal cord injuries, cerebral palsy, and stroke. This makes the study’s success particularly significant, not just for those with MS, but for a wider community of patients affected by similar conditions.What is Multiple Sclerosis (MS)?Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system—including the brain and spinal cord. In MS, the immune system mistakenly attacks the protective sheath (myelin) that covers nerve fibers, disrupting the communication between the brain and the rest of the body. Over time, this can lead to nerve damage and deterioration.Common Symptoms of MS:Muscle spasticity or stiffnessFatigueDifficulty walking or maintaining balanceVision problems (e.g., blurred or double vision)Numbness or tingling, especially in the limbsCognitive difficultiesBladder and bowel dysfunctionPain or muscle crampsSymptoms can vary widely depending on the area of the nervous system affected, and they often come and go in episodes known as relapses.How is MS Diagnosed?Diagnosing MS can be complex and typically involves a combination of:Neurological exams to assess reflexes, vision, coordination, and balanceMRI scans to detect lesions or areas of demyelination in the brain or spinal cordLumbar puncture (spinal tap) to examine cerebrospinal fluid for specific immune markersEvoked potential tests to measure electrical activity in response to stimuliThere’s no single test for MS, so diagnosis often involves ruling out other conditions with similar symptoms.

new oral treatment offers hope for ms patients battling muscle spasticity

Aarushi Bhadury

Developing These Health Conditions Before 55 Can Double The Risk Of Dementia

Nutrition

Neurologist Shares 10 Eating Habits For A Longer, Healthier Life

neurologist shares 10 eating habits for a longer, healthier life

BMI Calculators Cannot Predict Your Risk Of Death - Which Metric Can We Use?

bmi calculators cannot predict your risk of death - which metric can we use?

1 In 4 Indian Couples Are Overweight, Finds ICMR; How Obesity Is Now Becoming A Relationship Problem?

1 in 4 indian couples are overweight, finds icmr; how obesity is now becoming a relationship problem?

Parenting

The Dream Of 'Super Breed Babies' Is Becoming A Reality In Silicon Valley, Babies Are Now Not Just Born, But Selected

the dream of 'super breed babies' is becoming a reality in silicon valley, babies are now not just born, but selected

<span>Dementia</span> is a condition that can effectively dismantle a person’s life and everything they have worked for. Your memories, the way you think and behave, and all of these factors will slowly change as dementia progresses. While we have known about the disease for quite some time now, there are many aspects of it that we are still exploring, like what are some of its risk factors and causes, as these will help us find a cure for the disease. 

New research suggests that developing conditions like heart disease and diabetes before age 55 could significantly raise your chances of <span>developing dementia later in life</span>. The study also indicates that experiencing strokes or <span>mental health issues</span> such as anxiety and depression between ages 55 and 70 might double that risk. 

<h2>Key Conditions and <span rel="noindex">Critical Time Windows</span> </h2>

The study, published in Brain Communications, revealed that heart conditions, including heart disease and an irregular heartbeat called atrial fibrillation, along with diabetes, were most strongly linked to an increased <span>risk of dementia</span> when they appeared before age 55. However, for those between 55 and 70, mental health disorders like anxiety and depression, as well as strokes, were found to double the dementia risk. This suggests different conditions pose a higher risk at different stages of life. 

<h2>Link Between Chronic Conditions and Dementia </h2>

Researchers at the University of Oxford found that a large majority, about 80%, of people with dementia also have two or more chronic health problems. However, there hasn't been a clear understanding of how specific diseases, and when they occur, are connected to dementia. This study aimed to identify important periods in life where certain illnesses pose the biggest threat. They analysed health information from over 282,000 individuals in the UK Biobank, looking at patterns across 46 long-term health conditions. 

<h2>Other Risk Factors for Dementia </h2>

According to Stanford Health Care, many things can raise a person's chance of getting dementia, though some factors we can change and others we can't. Growing older significantly increases the risk for common types like Alzheimer's and vascular dementia. Your genes and family history also play a role, as certain genes can increase the risk for Alzheimer's and other rarer forms like Creutzfeldt-Jakob disease. 

However, having a family member with Alzheimer's doesn't guarantee you'll get it, and many without a family history still develop it. People with Down's syndrome often show signs of Alzheimer's in middle age. 

Lifestyle choices matter too. For example, smoking heavily increases dementia risk, possibly due to its link with hardened arteries. While heavy alcohol use seems to increase risk, moderate drinking might actually lower it compared to drinking a lot or not at all. Health conditions are also key factors. Atherosclerosis, where arteries harden, is a big risk for vascular dementia and might be linked to Alzheimer's. 

High "bad" cholesterol (LDL), high levels of an amino acid called homocysteine, and diabetes all raise the risk for both Alzheimer's and vascular dementia. Finally, if someone has mild cognitive impairment, they are at a much higher risk of developing dementia, with about 40% of those over 65 progressing to dementia within three years in one study. 

This research highlighted that individuals who had conditions like heart disease and diabetes in middle age and then later developed strokes and mental health disorders faced the highest chance of getting dementia. Experts em that considering all existing health issues is important when assessing someone's dementia risk, which could help in creating strategies to lower that risk at particular life stages. Future studies will explore if managing or preventing these health problems during these critical periods could reduce dementia rates. 

dementia

critical time windows

Risk Of Dementia

Health Conditions that Double The Risk Of Dementia

developing dementia later in life

mental health issues

Dementia is a condition that can effectively dismantle a person’s life and everything they have worked for. Your memories, the way you think and behave, and all of these factors will slowly change as dementia progresses. While we have known about the disease for quite some time now, there are many aspects of it that we are still exploring, like what are some of its risk factors and causes, as these will help us find a cure for the disease. New research suggests that developing conditions like heart disease and diabetes before age 55 could significantly raise your chances of developing dementia later in life. The study also indicates that experiencing strokes or mental health issues such as anxiety and depression between ages 55 and 70 might double that risk. Key Conditions and Critical Time Windows The study, published in Brain Communications, revealed that heart conditions, including heart disease and an irregular heartbeat called atrial fibrillation, along with diabetes, were most strongly linked to an increased risk of dementia when they appeared before age 55. However, for those between 55 and 70, mental health disorders like anxiety and depression, as well as strokes, were found to double the dementia risk. This suggests different conditions pose a higher risk at different stages of life. Link Between Chronic Conditions and Dementia Researchers at the University of Oxford found that a large majority, about 80%, of people with dementia also have two or more chronic health problems. However, there hasn't been a clear understanding of how specific diseases, and when they occur, are connected to dementia. This study aimed to identify important periods in life where certain illnesses pose the biggest threat. They analysed health information from over 282,000 individuals in the UK Biobank, looking at patterns across 46 long-term health conditions. Other Risk Factors for Dementia According to Stanford Health Care, many things can raise a person's chance of getting dementia, though some factors we can change and others we can't. Growing older significantly increases the risk for common types like Alzheimer's and vascular dementia. Your genes and family history also play a role, as certain genes can increase the risk for Alzheimer's and other rarer forms like Creutzfeldt-Jakob disease. However, having a family member with Alzheimer's doesn't guarantee you'll get it, and many without a family history still develop it. People with Down's syndrome often show signs of Alzheimer's in middle age. Lifestyle choices matter too. For example, smoking heavily increases dementia risk, possibly due to its link with hardened arteries. While heavy alcohol use seems to increase risk, moderate drinking might actually lower it compared to drinking a lot or not at all. Health conditions are also key factors. Atherosclerosis, where arteries harden, is a big risk for vascular dementia and might be linked to Alzheimer's. High "bad" cholesterol (LDL), high levels of an amino acid called homocysteine, and diabetes all raise the risk for both Alzheimer's and vascular dementia. Finally, if someone has mild cognitive impairment, they are at a much higher risk of developing dementia, with about 40% of those over 65 progressing to dementia within three years in one study. Insights for Future Prevention This research highlighted that individuals who had conditions like heart disease and diabetes in middle age and then later developed strokes and mental health disorders faced the highest chance of getting dementia. Experts em that considering all existing health issues is important when assessing someone's dementia risk, which could help in creating strategies to lower that risk at particular life stages. Future studies will explore if managing or preventing these health problems during these critical periods could reduce dementia rates. 

developing these health conditions before 55 can double the risk of dementia

You Are Much Less Likely To Get Opioid Prescriptions For Lower Back Pain Than Before- Is Healthcare Getting Better?

RFK Jr. And Trump Cabinet Want Psychedelics To Be Legal After FDA Shut Down; What This Means For The Controversial Drug?

rfk jr. and trump cabinet want psychedelics to be legal after fda shut down; what this means for the controversial drug?

Physician Associates Or Assistant Doctors? Government Review Urges Renaming To Avoid Misunderstandings

physician associates or assistant doctors? government review urges renaming to avoid misunderstandings

What's The Confusion! Why Most Women Don’t Know When To Start Mammogram Screenings?

what's the confusion! why most women don’t know when to start mammogram screenings?

Emergency rooms are handing out significantly fewer <span>opioid prescriptions</span> to people experiencing <span>lower back pain</span>. Researchers reported in the Annals of Emergency Medicine on July 12 that the rate of opioid prescriptions for back pain in ERs dropped by more than half between 2016 and 2022. 

<h2>Dramatic <span rel="noindex">Decline in Opioid Prescribing</span> </h2>

Just a few years ago, in 2016, almost one out of every three visits to the ER for back pain ended with a prescription for opioid painkillers. But by 2022, that number had fallen dramatically to just over one in ten visits. This big drop means that doctors are learning from the available information and changing the way they practice medicine, especially as more people become aware of the widespread problems caused by opioid addiction. It's a positive sign that medical professionals are actively working to curb the opioid crisis. 

<h2>Understanding the Study and Patient Experience </h2>

To figure this out, researchers looked at records from nearly 53 million ER visits for low back pain that happened between 2016 and 2022. These records were gathered by a national health statistics centre. The study found that when people went to the ER for back pain, they were usually in a lot of discomfort, rating their pain at more than 7 out of 10. On average, they had to wait about 37 minutes before a doctor saw them and spent around four hours in the emergency room getting treatment. 

<h2>Why Opioid Usage Is Risky For Patients</h2>

A 2023 study even found that opioids may not be as effective for back pain. Published in the JAMA network, a 2023 study conducted a trial on those who were experiencing back pain. The trial involved 347 adults who had been experiencing pain for up to 12 weeks. Everyone in the study received standard care, which included reassurance, advice to avoid bed rest, and encouragement to stay active. Half of the participants also received a combination of oxycodone and naloxone (an opioid), while the other half received a placebo (a dummy pill).

The study also revealed that while side effects were similar for both groups, there was a significant difference in the risk of opioid misuse. One year later, 20% of the participants who took opioids were at risk of misusing them, compared to only 10% of those who received the placebo. This suggests that even for short-term pain relief, opioids carry a greater risk of future misuse.

<h2><span rel="noindex">NSAIDs</span> Emerge as Preferred Treatment </h2>

Now, when you go to the ER with low back pain, nonsteroidal anti-inflammatory drugs, often called NSAIDs (like ibuprofen), are the most common painkillers prescribed. They're given to almost 29% of patients. It's not just about prescriptions either; fewer patients are actually given opioids while they are being treated in the ER. That number went down from 35% of cases in 2016 to less than 25% by 2020, showing a clear shift away from immediate opioid use during emergency care for back pain.

Even though there's good progress with reducing opioids, ER doctors still have some areas where they could improve how they treat back pain. For example, many patients with back pain are still getting X-rays that they don't really need. In 2022, about 37% of patients had an X-ray, which is pretty much the same as in 2015. In fact, in 2021, almost 44% of cases involved an X-ray, which was the highest rate. It's tough to get this number down because deciding whether to order an X-ray can be complicated and depends on what both the doctor and the patient think is best.

Opioid Prescriptions

Lower Back Pain

Opioid Prescriptions For Lower Back Pain

Healthcare

Decline in Opioid Prescribing

NSAIDs

Emergency rooms are handing out significantly fewer opioid prescriptions to people experiencing lower back pain. Researchers reported in the Annals of Emergency Medicine on July 12 that the rate of opioid prescriptions for back pain in ERs dropped by more than half between 2016 and 2022. Dramatic Decline in Opioid Prescribing Just a few years ago, in 2016, almost one out of every three visits to the ER for back pain ended with a prescription for opioid painkillers. But by 2022, that number had fallen dramatically to just over one in ten visits. This big drop means that doctors are learning from the available information and changing the way they practice medicine, especially as more people become aware of the widespread problems caused by opioid addiction. It's a positive sign that medical professionals are actively working to curb the opioid crisis. Understanding the Study and Patient Experience To figure this out, researchers looked at records from nearly 53 million ER visits for low back pain that happened between 2016 and 2022. These records were gathered by a national health statistics centre. The study found that when people went to the ER for back pain, they were usually in a lot of discomfort, rating their pain at more than 7 out of 10. On average, they had to wait about 37 minutes before a doctor saw them and spent around four hours in the emergency room getting treatment. Why Opioid Usage Is Risky For PatientsA 2023 study even found that opioids may not be as effective for back pain. Published in the JAMA network, a 2023 study conducted a trial on those who were experiencing back pain. The trial involved 347 adults who had been experiencing pain for up to 12 weeks. Everyone in the study received standard care, which included reassurance, advice to avoid bed rest, and encouragement to stay active. Half of the participants also received a combination of oxycodone and naloxone (an opioid), while the other half received a placebo (a dummy pill).The study also revealed that while side effects were similar for both groups, there was a significant difference in the risk of opioid misuse. One year later, 20% of the participants who took opioids were at risk of misusing them, compared to only 10% of those who received the placebo. This suggests that even for short-term pain relief, opioids carry a greater risk of future misuse.NSAIDs Emerge as Preferred Treatment Now, when you go to the ER with low back pain, nonsteroidal anti-inflammatory drugs, often called NSAIDs (like ibuprofen), are the most common painkillers prescribed. They're given to almost 29% of patients. It's not just about prescriptions either; fewer patients are actually given opioids while they are being treated in the ER. That number went down from 35% of cases in 2016 to less than 25% by 2020, showing a clear shift away from immediate opioid use during emergency care for back pain.Next Issues People Must Tackle Even though there's good progress with reducing opioids, ER doctors still have some areas where they could improve how they treat back pain. For example, many patients with back pain are still getting X-rays that they don't really need. In 2022, about 37% of patients had an X-ray, which is pretty much the same as in 2015. In fact, in 2021, almost 44% of cases involved an X-ray, which was the highest rate. It's tough to get this number down because deciding whether to order an X-ray can be complicated and depends on what both the doctor and the patient think is best.

you are much less likely to get opioid prescriptions for lower back pain than before- is healthcare getting better?

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.